Details of the Drug

General Information of Drug (ID: DMIWL5P)

• Drug Name: SAL-200

Indication

Disease Entry	ICD 11	Status	REF
Bacteremia	1A73	Phase 2	[1]
Staphylococcus infection	1B5Y	Phase 1	[2]

• Cross-matching ID: TTD ID: D02JBI
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT03089697) Phase IIa Clinical Study of N-Rephasin SAL200. U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT01855048) A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin SAL200 in Healthy Male Volunteers. U.S. National Institutes of Health.